Universal Cells

Universal Cells is a Seattle-based biotechnology company dedicated to developing, licensing, and commercializing stem cell therapies that overcome immune rejection, which can be used to create truly off-the-shelf therapeutic products. Using the company's proprietary genomic editing approach, Universal Cells engineers stem cells to prevent the expression of polymorphic human leukocyte antigen (HLA) molecules, eliminating the cause of donor tissue rejection and creating universal donor stem cells compatible with every patient.